AWH Aspira Women's Health
- 2.9000
- +0.0200+0.69%
Aspira Women's Health News
UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference...
UPDATE -- Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
Aspira Women's Health to Announce First Quarter Earnings Results and Host a Conference Call on Wednesday, May 15
AUSTIN, Texas, May 08, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyne
Aspira Women's Health Announces Publication of Two OvaWatch Peer-Reviewed Manuscripts
AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyne
Aspira Women's Health Enhances Its Commercial Offering With the Formal Launch of Longitudinal Monitoring Feature of OvaWatch
AUSTIN, Texas, May 02, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (Nasdaq: AWH), a bio-analytical based women's health company focused on the development of gyne
Aspira Women's Health Executive Minh Merchant Resigns
Aspira Women's Health Files for $100M Mixed Securities Shelf
Aspira Women's Health Price Target Maintained With a $3.30/Share by Cantor Fitzgerald
Aspira Women's Health Price Target Maintained With a $3.30/Share by Cantor Fitzgerald
Cantor Fitzgerald Reiterates Neutral on Aspira Womens Health, Maintains $3.3 Price Target
Cantor Fitzgerald analyst Ross Osborn reiterates Aspira Womens Health with a Neutral and maintains $3.3 price target.
Press Release: Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California
Aspira Women's Health Announces Anthem Blue Cross to Provide Coverage for OvaSuite(SM) in California Coverage represents approximately 6 million lives, including commercial, Medicare Advantage, and M
Aspira Women's Health Files to Sell 1.57M Shares for Holders
Aspira Women's Health Is Maintained at Neutral by Cantor Fitzgerald
Aspira Women's Health Is Maintained at Neutral by Cantor Fitzgerald
Cantor Fitzgerald Maintains Neutral on Aspira Womens Health, Lowers Price Target to $3.3
Cantor Fitzgerald analyst Ross Osborn maintains Aspira Womens Health (NASDAQ:AWH) with a Neutral and lowers the price target from $4 to $3.3.
Aspira Womens Health Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 0% Cantor Fitzgerald $4 → $3.3 Maintains Neutral 09/26/2023 21.21% Cantor Fitzgerald → $4 Reite
Q4 2023 Aspira Women's Health Inc Earnings Call
Aspira Women's Health GAAP EPS of -$0.30 Beats by $0.15, Revenue of $2.13M Misses by $0.42M
Earnings Call Summary | Aspira Women's Health(AWH.US) Q4 2023 Earnings Conference
The following is a summary of the Aspira Women's Health Inc. (AWH) Q4 2023 Earnings Call Transcript:Financial Performance:Aspira achieved a revenue growth of 15% in 2023 driven by its OvaSuite suite o
Aspira Womens Health Q4 EPS $(0.30) Beats $(0.45) Estimate, Sales $2.13M Miss $2.54M Estimate
Aspira Womens Health (NASDAQ:AWH) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.45) by 33.33 percent. This is a 45.45 percent increase over losses of
Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M
07:31 AM EDT, 03/28/2024 (MT Newswires) -- Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q4 Revenue $2.1M
Aspira Women's Health 4Q Loss/Shr 30c >AWH
Aspira Women's Health 4Q Loss/Shr 30c >AWH
Analysis
Price Target
No Data
